Importantly, symptoms of the 22q11.2 deletion syndrome include an increased prevalence of autoimmune disorders and B cell defects [47] that may well stem (at least in part) from lowered miR-185 levels and concomitant uncontrolled pERp1/MZB1 function. This evidence concerns the gene MZB1 and 22q11.2 deletion syndrome.